Posted 24th September 2018 by Jane Williams
Thanks to advancements in human tissue sample procedures, we have been able to make major breakthroughs in cancer research. In the twenty-first century, epidemiological and clinical evidence have supported the claim that changes in metabolism can affect oncogenesis and tumour response to therapy.
It has been observed that metabolic conditions such as hyperglycemia, obesity, hyperlipidemia, and insulin resistance are directly associated with increased risk of cancer development as well as the acceleration of tumour progression. These findings indicate that statins and metformin may help decrease cancer-related deaths.
Posted 8th August 2018 by Jane Williams
We caught up with Morgan Alexander, Professor of Biomedical Surfaces, University of Nottingham, to discuss the issues within the NHS, barriers to moving biomaterials work into the clinic, and exciting advancements within the biomaterials space.